Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma

Am J Med. 2020 Dec;133(12):e745-e746. doi: 10.1016/j.amjmed.2020.06.022. Epub 2020 Jul 31.

Authors

Pir Ahmad Shah¹, Janice Cho², Hasan Ahmad Hasan Albitar², Gregory Pajot², Mengfei Liu², Karthik Ravi²

Affiliations

¹ Liver Research Center, Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. Electronic address: [email protected].
² Mayo Clinic, Gastroenterology, Rochester, Minn.

PMID: 32739410
DOI: 10.1016/j.amjmed.2020.06.022

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Ammonia / blood
Brain Diseases / etiology*
Carcinoma, Hepatocellular / complications*
Female
Gastrointestinal Agents / therapeutic use
Humans
Hyperammonemia / etiology*
Lactulose / therapeutic use
Liver Neoplasms / complications*
Parenteral Nutrition, Total / adverse effects*
Rifaximin / therapeutic use

Substances

Gastrointestinal Agents
Lactulose
Ammonia
Rifaximin

Supplementary concepts

Fibrolamellar hepatocellular carcinoma